London, United Kingdom

Ian Zachary

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ian Zachary: A Visionary Inventor Making Waves in London

Introduction: Ian Zachary, based in London, GB, is a visionary inventor whose unwavering commitment to innovation has positioned him as a beacon of excellence in the field of technology. With a total of 4 patents to his name, Ian Zachary's groundbreaking work continues to inspire and shape the future of innovation.

Latest Patents: Ian Zachary's latest patents include the revolutionary inventions of Arginine derivatives with NP-1 antagonistic activity. These compounds, as per formula (I) and formula (II), have shown significant promise as NP-1 antagonists, paving the way for advancements in medical technology and therapeutic interventions.

Career Highlights: Throughout his illustrious career, Ian Zachary has made significant contributions to companies such as Ark Therapeutics Limited and Imperial Cancer Research Technology, Ltd. His innovative spirit and relentless pursuit of excellence have led to the development of cutting-edge technologies that have the potential to revolutionize the industry.

Collaborations: Ian Zachary has collaborated with esteemed professionals in the field, including coworkers such as David Lawrence Selwood and Haiyan Jia. These collaborations have fostered an environment of creativity and innovation, leading to the successful realization of groundbreaking inventions and patents.

Conclusion: Ian Zachary's dedication to innovation and his transformative contributions to the field of technology have solidified his reputation as a visionary inventor. His work serves as a testament to the power of creativity and the impact it can have on society. As Ian Zachary continues to push the boundaries of innovation, he remains a source of inspiration for future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…